Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS)
CNY 40.96
(0.2%)
CNY 40.96
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 224.81 Million | 155.64 Million | 114.72 Million | 104.65 Million | 116.66 Million | 64.79 Million |
| Net Income | 211.31 Million | 173.38 Million | 160.76 Million | 145.02 Million | 116.01 Million | 88.48 Million |
| Depreciation & Amortization | 62.32 Million | 48.78 Million | 34.22 Million | 29.66 Million | 26.18 Million | 23.35 Million |
| Deferred income taxes | -6.86 Million | 415.34 Thousand | -2.73 Million | -343 Thousand | -8.45 Million | 513.3 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -31.49 Million | -66.27 Million | -83.39 Million | -81.77 Million | -30.15 Million | -50.77 Million |
| Other non-cash items | 145.67 Million | -248.09 Thousand | 3.13 Million | 11.73 Million | 4.61 Million | 3.72 Million |
| Investing Cash Flow | 29.75 Million | -230.62 Million | -517.3 Million | -61.14 Million | -25.21 Million | -40.01 Million |
| Investments in PPE | -105.76 Million | -131.84 Million | -92.09 Million | -53.74 Million | -24.33 Million | -35.36 Million |
| Acquisitions | 1.05 Million | 192.75 Thousand | 128.63 Thousand | 53.75 Million | 24.39 Million | 354.5 Thousand |
| Investment purchases | -1.38 Billion | -2.11 Billion | -1.1 Billion | -119.5 Million | -16 Million | -5 Million |
| Sales/Maturities of investments | 1.52 Billion | 2.01 Billion | 675.46 Million | 112.09 Million | 15.06 Million | - |
| Other Investing Activities | -1.00 | 1.11 | 0.54 | -53.74 Million | -24.33 Million | 354.5 Thousand |
| Financing Cash Flow | -58.46 Million | -76.37 Million | 655.65 Million | -35.15 Million | -35.66 Million | -40.22 Million |
| Debt repayment | -17.1 Million | - | - | - | -500 Thousand | -59.5 Million |
| Dividends payments | -84.42 Million | -65.66 Million | - | -35.15 Million | -35.16 Million | -721.84 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 8.84 Million | -10.71 Million | 655.65 Million | -35.15 Million | -35.16 Million | 20 Million |
| Accounts receivables | -51.33 Million | 11.31 Million | -31.55 Million | -24.17 Million | -5.87 Million | -62.4 Million |
| Accounts payables | 50.84 Million | -34.76 Million | 66.48 Million | -58.24 Million | 40.7 Million | 52.35 Million |
| Inventory | -31 Million | -43.24 Million | -115.58 Million | 992.75 Thousand | -56.52 Million | -41.24 Million |
| Other working capital | -1.00 | 415.34 Thousand | -2.73 Million | -343.03 Thousand | -8.45 Million | -9.52 Million |
| Cash at beginning of period | 191.28 Million | 332.05 Million | 79.01 Million | 70.93 Million | 15.18 Million | 30.4 Million |
| Cash at end of period | 379.64 Million | 181.23 Million | 332.05 Million | 79.01 Million | 70.93 Million | 15.18 Million |
| Capital Expenditure | -105.76 Million | -131.84 Million | -92.09 Million | -53.74 Million | -24.33 Million | -35.36 Million |
| Effect of forex changes on cash | 8041.74 | 528.11 Thousand | -34.5 Thousand | -276.25 Thousand | -39.76 Thousand | 212.83 Thousand |
| Net cash flow / Change in cash | 188.35 Million | -150.81 Million | 253.03 Million | 8.08 Million | 55.74 Million | -15.22 Million |
| Free Cash Flow | 119.04 Million | 23.79 Million | 22.62 Million | 50.9 Million | 92.32 Million | 29.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 45.61 Million | 52.74 Million | 60.05 Million | 211.31 Million | 53.04 Million | 46.06 Million |
| Depreciation & Amortization | - | 17.54 Million | 17.54 Million | 62.32 Million | 17.23 Million | -27.01 Million |
| Deferred income taxes | - | - | - | -6.86 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -103.33 Million | - | -31.49 Million | -82.33 Million | -6.93 Million |
| Other non-cash items | -23.95 Million | -53.59 Million | -1.55 Million | 145.67 Million | 69.35 Million | 46.63 Million |
| Investing Cash Flow | -229.24 Million | -163.65 Million | -6.27 Million | 29.75 Million | 235.24 Million | -25.96 Million |
| Investments in PPE | -32.24 Million | -38.66 Million | -40.53 Million | -105.76 Million | -40.64 Million | -21.6 Million |
| Acquisitions | - | 4300.00 | -34.31 Million | 1.05 Million | 1.01 Million | 0.52 |
| Investment purchases | -242 Million | -130 Million | -10.74 Million | -1.38 Billion | 24.25 Million | -271.04 Million |
| Sales/Maturities of investments | 45 Million | 5 Million | 45 Million | 1.52 Billion | 250.6 Million | 266.68 Million |
| Other Investing Activities | - | -124.99 Million | 34.31 Million | -1.00 | -1.00 | - |
| Financing Cash Flow | 21.47 Million | 22.49 Million | 29.59 Million | -58.46 Million | -67.33 Million | 5.13 Million |
| Debt repayment | -20.95 Million | -22.91 Million | -29.83 Million | -17.1 Million | -17.1 Million | - |
| Dividends payments | - | -416.14 Thousand | -241.5 Thousand | -84.42 Million | -84.42 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 519.38 Thousand | -416.14 Thousand | -241.5 Thousand | 8.84 Million | -23.49 Thousand | 5.13 Million |
| Accounts receivables | - | -63.25 Million | - | -51.33 Million | -51.33 Million | -16.11 Million |
| Accounts payables | - | - | - | 50.84 Million | - | - |
| Inventory | - | -40.07 Million | - | -31 Million | -31 Million | 9.17 Million |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 306.34 Million | 459.2 Million | 379.64 Million | 191.28 Million | 154.75 Million | 114.65 Million |
| Cash at end of period | 118.09 Million | 299.76 Million | 461.5 Million | 379.64 Million | 379.64 Million | 152.45 Million |
| Capital Expenditure | -32.24 Million | -38.66 Million | -40.53 Million | -105.76 Million | -40.64 Million | -21.6 Million |
| Effect of forex changes on cash | - | 121.65 Thousand | 38.6 Thousand | 8041.74 | -313.27 Thousand | -109.64 Thousand |
| Net cash flow / Change in cash | -188.24 Million | -159.44 Million | 81.86 Million | 188.35 Million | 224.89 Million | 37.79 Million |
| Free Cash Flow | -10.58 Million | -57.06 Million | 17.96 Million | 119.04 Million | 16.66 Million | 37.13 Million |
BZDLF
HSCS
2001
ELN
9616
AKG